Benralizumab, the first new treatment for asthma and chronic obstructive pulmonary disease (COPD), is being called a ‘game-changer’ by researchers. Initially reserved for severe cases, new studies sug

Treatment for asthma and chronic obstructive pulmonary disease (COPD), which contributed to Sinead O'Connor's death last year, has been "stuck in the 20th century." But no longer, says Dr. Sanjay Ramakrishnan of the University of Western Australia,

Scientists discover benralizumab could tackle suffocating attacks for people with both asthma and chronic obstructive pulmonary disease (COPD)

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation.

The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an injection is more effective than the current care of steroid tablets and cuts the need for further treatment by 30 per cent, according to a study.

King’s College, London researchers say they have found the first new treatment for asthma attacks in 50 years. Benralizumab injection dampens part of the immune system that can go into overdrive in flare-ups of both asthma and chronic obstructive pulmonary disease and can be used routinely.